FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used in diagnosing chronic active lymphocytic myocarditis in patients with "idiopathic" atrial fibrillation (AF). That is ensured by determining cardiac myosin-binding protein C and stimulating growth factor 2 in patient's blood. That is followed by calculating prognostic coefficients of these values and increasing the threshold values of cardiac myosin-binding C protein values greater than 0.218 ng/ml and stimulating growth factor 2 more than 22.06 ng/ml to predict the presence of chronic active myocarditis.
EFFECT: use of this invention enables non-invasive diagnosis of chronic lymphocytic myocarditis in patients with "idiopathic" form of AF.
1 cl, 4 ex, 2 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTING PATIENTS WITH LONG-TERM PERSISTENT ATRIAL FIBRILLATION FOR EFFECTIVE CATHETER TREATMENT | 2020 |
|
RU2749552C1 |
METHOD FOR SCINTIGRAPHIC DIAGNOSTICS OF CHRONIC MYOCARDITIS | 2017 |
|
RU2642928C1 |
METHOD FOR SELECTING PATIENTS WITH ATRIAL FIBRILLATION FOR MYOCARDIAL SCINTIGRAPHY PROCEDURE FOR DIAGNOSIS OF CHRONIC LATENT MYOCARDITIS | 2015 |
|
RU2581717C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVORABLE REMODELING OF THE LEFT VENTRICLE OF THE HEART IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL INFARCTION WITH ST STENT ELEVATION WITHIN 6 MONTHS OF THE ONSET OF THE DISEASE | 2017 |
|
RU2662093C1 |
METHOD OF IMMUNOLOGICAL PREDICTION OF SUDDEN CORONARY DEATH | 2023 |
|
RU2810015C1 |
METHOD FOR ASSESSING THE PROBABILITY OF DEVELOPING UNFAVORABLE HEART LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION | 2021 |
|
RU2770285C1 |
METHOD FOR PREOPERATIVE PREDICTION OF THE RISK OF LATE RECURRENCE OF ATRIAL FIBRILLATION AFTER THE PRIMARY PROCEDURE OF ENDOCARDIAL RADIOFREQUENCY ABLATION | 2021 |
|
RU2767133C1 |
METHOD OF TREATING PAROXYSMAL FORM OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC HEART FAILURE IN ARTERIAL HYPERTENSION | 2019 |
|
RU2703517C1 |
METHOD FOR PREDICTING COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER CARDIAC SURGERIES WITH ARTIFICIAL CIRCULATION | 2017 |
|
RU2680602C1 |
METHOD FOR PREDICTION OF RISK OF LATE POST-ABLATING RELAPSE OF ATRIAL FIBRILLATION IN PATIENTS WITH ATRIAL FIBRILLATION WITHOUT STRUCTURAL AND FUNCTIONAL CHANGES IN MYOCARDIUM BASED ON RADIOMIC ANALYSIS OF EPICARDIAL ADIPOSE TISSUE | 2022 |
|
RU2789384C1 |
Authors
Dates
2020-12-22—Published
2020-02-11—Filed